LON:HVO hVIVO (HVO) Share Price, News & Analysis → Bible Shocker: Have You Seen Elon Musk’s Miracle? (From InvestorPlace) (Ad) Free HVO Stock Alerts GBX 27.50 +0.25 (+0.92%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range 27▼ 2850-Day Range 26.70▼ 3052-Week Range 14▼ 32Volume923,453 shsAverage Volume3.16 million shsMarket Capitalization£187.10 millionP/E Ratio1,375.00Dividend Yield0.72%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendHeadlinesStock AnalysisChartCompetitorsDividendHeadlines Get hVIVO alerts: Email Address Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. About hVIVO Stock (LON:HVO)hVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies. The Group's fast-growing services business includes a unique portfolio of 10+ human challenge models to test a broad range of infectious and respiratory disease products, world class challenge agent manufacturing, specialist drug development and clinical consultancy services via its Venn Life Sciences brand, and a lab offering via its hLAB brand, which includes virology, immunology biomarker and molecular testing. The Group offers additional clinical field trial services such as patient recruitment and clinical trial site services. hVIVO runs challenge studies in London from its Whitechapel quarantine clinic, its state-of-the-art QMB clinic with its highly specialised on-site virology and immunology laboratory, and its clinic in Plumbers Row. To recruit volunteers / patients for its studies, the Company leverages its unique clinical trial recruitment capacity via its FluCamp volunteer screening facilities in London and Manchester.Written by Jeffrey Neal JohnsonRead More HVO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HVO Stock News HeadlinesMay 11, 2024 | americanbankingnews.comhVIVO (LON:HVO) Share Price Passes Above Fifty Day Moving Average of $28.29May 3, 2024 | morningstar.comhVIVO PLC HVOApril 21, 2024 | proactiveinvestors.com.auhVIVO primed for success, says US investmentApril 15, 2024 | uk.finance.yahoo.com2 under-the-radar growth stocks I’ve just bought for my Stocks and Shares ISAApril 10, 2024 | finance.yahoo.comIs hVIVO plc's (LON:HVO) Recent Stock Performance Tethered To Its Strong Fundamentals?April 9, 2024 | msn.comIs hVIVO still a top UK stock for growth after today’s full-year results?April 9, 2024 | finance.yahoo.comhVIVO achieves record revenue and initiates dividend policy following successful yearMarch 15, 2024 | msn.comTesla bearishness is overdone, and the company's board should do these 3 things to send the stock soaring again, Wedbush saysMarch 13, 2024 | msn.comSam Altman said he texted Elon Musk after the billionaire sued himMarch 13, 2024 | msn.comFTSE 100 ends higher as UK economy returns to growthMarch 13, 2024 | uk.style.yahoo.comStock market today: US stocks hold steady after rally as investors wait on more economic dataMarch 13, 2024 | uk.finance.yahoo.comGold rally may be 'a little bit ahead of itself': StrategistMarch 13, 2024 | uk.finance.yahoo.comThe Average Monthly Mortgage in Every State Based on Your Down PaymentMarch 13, 2024 | msn.comBitcoin is going to 'eat' gold because it has all of its positives and none of the negatives, Michael Saylor saysMarch 13, 2024 | uk.finance.yahoo.comRothesay buys 6 billion pound Scottish Widows bulk annuities from LloydsMarch 13, 2024 | uk.news.yahoo.comStock market today: US futures flatline after S&P 500 hits another record highMarch 13, 2024 | uk.finance.yahoo.com13 Best Biotech Stocks To Buy Under $20March 12, 2024 | uk.finance.yahoo.comOld Mutual expects up to 45 per cent jump in profit on ‘exceptional growth’ in new businessMarch 12, 2024 | msn.comIs 2024 a once-in-a-decade chance to get rich with growth stocks?March 12, 2024 | msn.comThis FTSE 100 super-share keeps on thrashing the stock market!March 11, 2024 | uk.news.yahoo.comBoE's Mann: long way for inflation pressures to be consistent with 2% targetMarch 11, 2024 | uk.finance.yahoo.comGLOBAL MARKETS-Asian stocks rise ahead of US CPI; yen perks up on BOJ chatterMarch 11, 2024 | uk.news.yahoo.comReddit's planned IPO share price seems high, unless you look at its AI revenueMarch 11, 2024 | uk.news.yahoo.comReddit aims to raise $500 mn in stock market debutMarch 11, 2024 | uk.finance.yahoo.comMicroStrategy increases bitcoin holdings by 12K BTCSee More Headlines Receive HVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for hVIVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/19/2018Ex-Dividend for 5/20 Dividend4/18/2024Today5/18/2024Dividend Payable5/20/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:HVO Previous SymbolLON:RVG CUSIPN/A CIKN/A Webhvivo.com Phone+44-20-77561300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.02 Trailing P/E Ratio1,375.00 Forward P/E Ratio21.14 P/E GrowthN/ANet Income£16.11 million Net Margins27.47% Pretax MarginN/A Return on Equity59.09% Return on Assets9.58% Debt Debt-to-Equity Ratio36.50 Current Ratio1.48 Quick Ratio1.16 Sales & Book Value Annual Sales£58.67 million Price / Sales3.19 Cash FlowGBX 5.57 per share Price / Cash Flow4.94 Book ValueGBX 5 per share Price / Book5.50Miscellaneous Outstanding Shares680,370,000Free FloatN/AMarket Cap£187.10 million OptionableNot Optionable Beta1.02 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesDr. Yamin Mohammed Khan Ph.D. (Age 54)CEO & Director Mr. Stephen PinkertonCFO & Exec. DirectorMr. Andrew CatchpoleChief Scientific OfficerDr. Maurice N. Treacy Ph.D.Chief Commercial OfficerMs. Teja Marathe-SarvadikarHead of QAKey CompetitorsArix BioscienceLON:ARIX4basebioLON:4BBFaron Pharmaceuticals OyLON:FARNAvacta GroupLON:AVCTVerona Pharma plc (VRP.L)LON:VRPView All Competitors HVO Stock Analysis - Frequently Asked Questions How have HVO shares performed in 2024? hVIVO's stock was trading at GBX 23.75 at the start of the year. Since then, HVO stock has increased by 15.8% and is now trading at GBX 27.50. View the best growth stocks for 2024 here. How were hVIVO's earnings last quarter? hVIVO plc (LON:HVO) posted its quarterly earnings data on Thursday, April, 19th. The company reported ($16.50) earnings per share for the quarter, missing the consensus estimate of ($10.90) by $5.60. hVIVO had a trailing twelve-month return on equity of 59.09% and a net margin of 27.47%. How often does hVIVO pay dividends? What is the dividend yield for hVIVO? hVIVO announced a dividend on Tuesday, April 9th. Investors of record on Thursday, April 18th will be given a dividend of GBX 0.20 per share on Monday, May 20th. This represents a dividend yield of 0.68%. The ex-dividend date of this dividend is Thursday, April 18th. The official announcement can be viewed at this link. Read our dividend analysis for HVO. What other stocks do shareholders of hVIVO own? Based on aggregate information from My MarketBeat watchlists, some companies that other hVIVO investors own include ValiRx (VAL), boohoo group (BOO), Petrofac (PFC), Falanx Group (FLX), IQE (IQE), Scirocco Energy Plc (SOLO.L) (SOLO), CyanConnode (CYAN), Eckoh (ECK), Enanta Pharmaceuticals (ENTA) and Lloyds Banking Group (LLOY). How do I buy shares of hVIVO? Shares of HVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:HVO) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding hVIVO plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.